Recombinant antibodies for in vivo use

by | Mar 26, 2024 | Cancer, Immunology, in vivo Studies, Neurology

FEATURED PRODUCTS FROM BIO X CELL

Bio X Cell Recombinant antibodies for in-vivo use

RecombiMAb™ Primary Antibodies

RecombiMAb™ antibodies use mouse or human IgG constant regions instead of the typical rat or hamster IgG constant regions, resulting in improved in vivo activity and reduced immunogenicity in mouse and humanized mouse models. In some syngeneic mouse tumor models, particularly in BALB/c mice, repeated rat or hamster IgG administration can result in complications from hypersensitivity reactions. Using the RecombiMAb™ antibody instead of wild-type clones may reduce antibody immunogenicity and alleviate hypersensitivity reactions. RecombiMAb™ antibodies also overcome the limitations of traditionally manufactured antibodies by ensuring high lot-to-lot consistency and data reproducibility across experiments.

What Are RecombiMAb™ Recombinant Antibodies?

Bio X Cell RecombiMAb™ monoclonal antibodies are recombinant antibodies with the exact same antigen-binding variable domains as the traditional antibodies that they are derived from. The epitope to which the RecombiMAb™ antibody binds is identical to that of the matching traditionally produced clone. This is accomplished by sequencing and cloning the antibody-coding genes into high-yield expression vectors which are then expressed in mammalian cells to generate the recombinant antibody.

Consistent and Highly Reproducible Data

RecombiMAb™ antibodies are derived from a defined DNA and amino acid sequence encoding only one heavy and one light chain. RecombiMAb™ antibodies are not susceptible to genetic drift, gene loss or gene mutations. This ensures extremely high lot-to-lot consistency and data reproducibility from experiment to experiment.

Species Matching Chimerization

RecombiMAb™ antibodies are provided as chimeric antibodies with mouse or human IgG constant regions instead of the typical rat or hamster constant regions. This means improved in vivo activity and reduced immunogenicity in mouse models or humanized mouse models.

Available Fc Domain Silencing

Engaging Fc-mediated antibody effector functions through Fcγ receptor and complement interactions can be detrimental to certain antibody mechanisms of action. For example, antibodies which block cell surface receptors or cytokines and do not require Fc-effector functions. This is especially important for immune checkpoint blocking antibodies where target cell depletion is not desired.

Select RecombiMAb™ antibodies are available in multiple Fc silenced versions. These Fc silenced versions have mutations in the Fc fragment of the antibody rendering them unable to bind to endogenous Fcγ receptors or complement in vivo thereby eliminating Fc-mediated antibody effector functions. Available Fc silencing mutations include D265A, S228P, and LALA-PG.

Formulated for in vivo Use

RecombiMAb™ antibodies are offered with the same purity and in vivo formulations that Bio X Cell is known for. Our recombinant antibodies are ultra-pure and free of preservatives, stabilizers, and carrier proteins, making them ideal for in vivo applications.

Why Choose RecombiMAb™ Recombinant Antibodies?

Traditional monoclonal antibodies created using hybridoma technology are produced by fusing a B cell from an immunized animal with an immortalized myeloma cell. While this process produces highly specific and consistent monoclonal antibodies it does have some drawbacks. Hybridoma cells are susceptible to genetic drift, gene loss, and gene mutations which can result in slight changes in binding specificity and antibody affinity over time. While Bio X Cell’s optimized antibody manufacturing process utilizes multiple measures to avoid hybridoma genetic drift and lot to lot variability as much as is achievable, some level is unavoidable. Further, since traditional hybridomas are created using immunized animals (typically rats or hamsters) the species of the antibody cannot be altered. This can be problematic when the species of the antibody does not match the species of the experimental animal. For example, injecting rat IgG into a mouse repeatedly over the time course of an experiment has the potential to induce an immune response against the injected antibody in the mouse leading to reduced antibody effectiveness and/or a hypersensitivity reaction. Recombinant antibodies do not suffer from these drawbacks.

RecombiMAb™ Recombinant Antibodies Features

Exceptional Purity: Each lot is QC tested for purity using SDS-PAGE and are preservative, stabilizer, and carrier protein-free.

Binding Validation: Each lot of RecombiMAb™ product is validated for antigen binding by immunoblot.

Ultra-low Endotoxin Levels: The level of endotoxin is QC tested for each lot. Our RecombiMAb™ products are ≤ 1EU/mg. If endotoxin levels below 1EU/mg are required, please contact technical support to discuss your needs.

Pathogen Free: Each lot of RecombiMAb™ product is screened for an exhaustive panel of murine pathogens. The results are detailed on product-specific datasheets, to help you adhere to IACUC and Animal Facility requirements.

Low Protein Aggregation: Each lot of RecombiMAb™ is QC tested for aggregate level and guaranteed to be below 5% of the total protein.

ABOUT BIO X CELL

Antibodies For In Vivo Research

Bio X Cell antibodies are formulated for in vivo experiments and used extensively in animal models of human disease. They feature greater than 95% purity, ultra-low endotoxin levels, and are presevative, stabilizer, and carrier protein-free. Bio X Cell has developed a wide range of antibodies for immuno-oncology, immunology, and neuroscience research. Their products are cited in over 15,000 publications that detail a broad range of applications, including in vivo cell-specific depletion, cytokine neutralization, immune checkpoint blockade, and more.

 

    • Exceptional Purity
    • Pathogen Free
    • Ultra-low Endotoxin Level
    • Advanced Binding Validation
    • Low Protein Aggregation
    • Marching Isotype Control Antibodies

All products listed on this site and sold through LAB-A-PORTER Limited are for research use only (RUO). Not for human use. Not for therapeutic or diagnostic use.

Reference: 

  1. Bio X Cell, ‘Recombinant antibodies for in vivo use’. Available at https://bioxcell.com/educational-articles/recombinant-antibodies/

Learn more on our comprehensive in-vivo research reagents today.

Contact us
Share This